Mint Tower Capital Management B.V. Abb Vie Inc. Put Options Transaction History

Mint Tower Capital Management B.V.

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $3.04 Million - $3.65 Million	-22,000 Reduced 59.46%	15,000 $2.42 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $80,526 - $92,358	-600 Reduced 1.6%	37,000 $4.97 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $2.01 Million - $2.55 Million	-14,600 Reduced 27.97%	37,600 $5.76 Million
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $5.02 Million - $6.22 Million	38,000 Added 267.61%	52,200 $8.46 Million
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $762,753 - $965,103	-7,100 Reduced 33.33%	14,200 $1.92 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $266,000 - $301,950	2,500 Added 13.3%	21,300 $2.3 Million
Q2 2021 Aug 02, 2021	SELL	$105.21 - $117.21 $1.55 Million - $1.72 Million	-14,700 Reduced 43.88%	18,800 $2.12 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $1.69 Million - $1.86 Million	16,500 Added 97.06%	33,500 $3.58 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $2.66 Million - $3.59 Million	-33,000 Reduced 66.0%	17,000 $1.8 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $3.15 Million - $3.79 Million	50,000 New	50,000 $3.79 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

Stay updated on Mint Tower Capital Management B.V. with notifications on news.